Estados Unidos

Mercado internacional de ações

Cadastro completo das bolsas americanas, histórico de preços, demonstrações financeiras, indicadores, rentabilidade, crescimento, endividamento, qualidade, mercado e dividendos.

Ações ordinárias, common stocks e ADRs/ADSs ativos; ETFs, units, warrants, direitos e preferenciais ficam fora desta aba.

Explorar REITs americanos

5.660

ações no escopo

5.646

ligadas à SEC

5.651

com preços

5.119

com fundamentos

18/09/2026

última cotação

SEC como fonte principal

Identidade regulatória, demonstrações anuais e trimestrais e dividendos declarados vêm do EDGAR/XBRL.

Cadastro oficial

Nasdaq Trader cobre Nasdaq, NYSE, NYSE American, NYSE Arca, Cboe e IEX.

Proveniência explícita

A janela pública da Nasdaq tem prioridade; Yahoo Finance completa o período anterior sem ser rotulado como oficial.

Destaques do mercado

Ranking de Stocks

Listas objetivas calculadas sobre todo o universo de ações dos EUA, com preços de mercado e fundamentos SEC.

Top 5

Todas as ações

502 resultados

Ação	Bolsa	Preço	Valor de mercado	P/L

BCAXBicara Therapeutics Inc. - Common Stock	NASDAQ	US$ 22,19	US$ 1,21 tri	—	3.022,23x	-34,36%	—	Preço 16/09/2026 SEC 31/12/2025
LLYEli Lilly and Company Common Stock	NYSE	US$ 1.115,70	US$ 1,00 tri	48,61x	37,81x	77,78%	0,56%	Preço 11/09/2026 SEC 31/12/2025
JNJJohnson & Johnson Common Stock	NYSE	US$ 265,58	US$ 645,20 bi	24,08x	7,91x	32,87%	1,94%	Preço 11/09/2026 SEC 28/12/2025
AKTXAkari Therapeutics Plc - American Depositary Shares	NASDAQ	US$ 9,16	US$ 616,73 bi	—	21.770,89x	-61,06%	—	Preço 18/09/2026 SEC 31/12/2025
ONCBeOne Medicines Ltd. - American Depositary Shares	NASDAQ	US$ 346,51	US$ 511,04 bi	1.823,74x	117,18x	6,58%	—	Preço 11/09/2026 SEC 31/12/2025
ABBVAbbVie Inc. Common Stock	NYSE	US$ 263,96	US$ 468,00 bi	111,85x	-144,98x	-130,92%	2,52%	Preço 18/09/2026 SEC 31/12/2025
MRKMerck & Company, Inc. Common Stock (new)	NYSE	US$ 143,93	US$ 360,83 bi	19,77x	6,85x	34,66%	2,28%	Preço 11/09/2026 SEC 31/12/2025
NVSNovartis AG Common Stock	NYSE	US$ 137,16	US$ 261,72 bi	19,18x	5,62x	30,00%	—	Preço 11/09/2026 SEC 31/12/2025
BDRXBiodexa Pharmaceuticals plc - American Depositary Shares	NASDAQ	US$ 0,96	US$ 216,79 bi	—	19.007,90x	-55,98%	—	Preço 16/09/2026 SEC 31/12/2025
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	NYSE	US$ 48,13	US$ 207,70 bi	34,68x	13,02x	39,41%	—	Preço 11/09/2026 SEC 31/12/2025
ABTAbbott Laboratories Common Stock	NYSE	US$ 102,61	US$ 179,36 bi	27,58x	3,40x	12,36%	2,34%	Preço 18/09/2026 SEC 31/12/2025
PFEPfizer, Inc. Common Stock	NYSE	US$ 27,72	US$ 158,36 bi	20,38x	1,82x	8,96%	6,20%	Preço 11/09/2026 SEC 31/12/2025
VRTXVertex Pharmaceuticals Incorporated - Common Stock	NASDAQ	US$ 515,44	US$ 132,98 bi	33,64x	7,12x	21,18%	—	Preço 11/09/2026 SEC 31/12/2025
BMYBristol-Myers Squibb Company Common Stock	NYSE	US$ 63,73	US$ 129,95 bi	18,42x	7,02x	38,12%	3,91%	Preço 15/09/2026 SEC 31/12/2025
LGVNLongeveron Inc. - Class A Common stock	NASDAQ	US$ 7,33	US$ 128,84 bi	—	22.702,40x	-400,07%	—	Preço 11/09/2026 SEC 31/12/2025
REGNRegeneron Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 781,49	US$ 84,87 bi	18,84x	2,72x	14,41%	—	Preço 11/09/2026 SEC 31/12/2025
SNYSanofi - American Depositary Shares	NASDAQ	US$ 42,77	US$ 52,15 bi	6,71x	0,73x	10,95%	—	Preço 11/09/2026 SEC 31/12/2025
TEVATeva Pharmaceutical Industries Limited Ordinary Shares	NYSE	US$ 38,72	US$ 44,52 bi	32,00x	5,63x	17,82%	—	Preço 14/09/2026 SEC 31/12/2025
ATHEAlterity Therapeutics Limited - American Depositary Shares	NASDAQ	US$ 3,91	US$ 35,69 bi	—	841,64x	-28,65%	—	Preço 18/09/2026 SEC 30/06/2025
RPRXRoyalty Pharma plc - Class A Ordinary Shares	NASDAQ	US$ 58,61	US$ 33,08 bi	32,93x	3,41x	7,94%	—	Preço 11/09/2026 SEC 31/12/2025
ZTSZoetis Inc. Class A Common Stock	NYSE	US$ 72,97	US$ 32,39 bi	12,12x	9,72x	80,25%	2,78%	Preço 11/09/2026 SEC 31/12/2025
ALNYAlnylam Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 239,56	US$ 32,26 bi	102,82x	40,88x	39,76%	—	Preço 18/09/2026 SEC 31/12/2025
ROIVRoivant Sciences Ltd. - Common Shares	NASDAQ	US$ 40,82	US$ 28,32 bi	—	5,35x	-5,66%	—	Preço 11/09/2026 SEC 31/03/2026
NCNANuCana plc - American Depositary Shares	NASDAQ	US$ 1,32	US$ 27,47 bi	—	1.129,16x	-120,66%	—	Preço 11/09/2026 SEC 31/12/2025
ZLABZai Lab Limited - American Depositary Shares	NASDAQ	US$ 24,14	US$ 26,44 bi	—	36,95x	-24,53%	—	Preço 11/09/2026 SEC 31/12/2025
INSMInsmed Incorporated - Common Stock	NASDAQ	US$ 129,41	US$ 25,75 bi	—	34,85x	-172,78%	—	Preço 11/09/2026 SEC 31/12/2025
JAZZJazz Pharmaceuticals plc - Ordinary Shares	NASDAQ	US$ 245,80	US$ 14,99 bi	—	3,47x	-8,25%	—	Preço 11/09/2026 SEC 31/12/2025
ASNDAscendis Pharma A/S - Ordinary Share	NASDAQ	US$ 236,72	US$ 14,67 bi	—	-90,11x	140,05%	—	Preço 18/09/2026 SEC 31/12/2025
CORTCorcept Therapeutics Incorporated - Common Stock	NASDAQ	US$ 111,81	US$ 13,42 bi	136,35x	20,71x	15,38%	—	Preço 16/09/2026 SEC 31/12/2025
SMMTSummit Therapeutics Inc. - Common Stock	NASDAQ	US$ 17,55	US$ 13,12 bi	—	19,92x	-163,86%	—	Preço 11/09/2026 SEC 31/12/2025
BBIOBridgeBio Pharma, Inc. - Common Stock	NASDAQ	US$ 67,43	US$ 12,91 bi	—	-6,22x	—	—	Preço 16/09/2026 SEC 31/12/2025
BMRNBioMarin Pharmaceutical Inc. - Common Stock	NASDAQ	US$ 64,45	US$ 12,72 bi	35,81x	2,09x	5,73%	—	Preço 15/09/2026 SEC 31/12/2025
MDGLMadrigal Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 534,49	US$ 11,99 bi	—	19,90x	-47,83%	—	Preço 11/09/2026 SEC 31/12/2025
ELANElanco Animal Health Incorporated Common Stock	NYSE	US$ 23,17	US$ 11,50 bi	—	1,76x	-3,54%	—	Preço 11/09/2026 SEC 31/12/2025
HCMHUTCHMED (China) Limited - American Depositary Shares	NASDAQ	US$ 12,82	US$ 11,18 bi	24,65x	8,94x	36,52%	—	Preço 11/09/2026 SEC 31/12/2025
AXSMAxsome Therapeutics, Inc. - Common Stock	NASDAQ	US$ 204,07	US$ 10,15 bi	—	114,98x	-207,46%	—	Preço 15/09/2026 SEC 31/12/2025
RDYDr. Reddy's Laboratories Ltd Common Stock	NYSE	US$ 11,90	US$ 9,93 bi	0,18x	0,03x	16,98%	—	Preço 11/09/2026 SEC 31/03/2025
PTGXProtagonist Therapeutics, Inc. - Common Stock	NASDAQ	US$ 148,18	US$ 9,42 bi	—	15,32x	-21,17%	—	Preço 11/09/2026 SEC 31/12/2025
KZIAKazia Therapeutics Limited - American Depositary Shares	NASDAQ	US$ 11,26	US$ 9,11 bi	—	—	—	—	Preço 14/09/2026 SEC 30/06/2025
ARWRArrowhead Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 66,48	US$ 8,89 bi	—	17,66x	-0,32%	—	Preço 18/09/2026 SEC 30/09/2025
TGTXTG Therapeutics, Inc. - Common Stock	NASDAQ	US$ 54,00	US$ 8,72 bi	19,49x	13,45x	69,01%	—	Preço 14/09/2026 SEC 31/12/2025
IONSIonis Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 54,21	US$ 8,67 bi	—	17,74x	-77,98%	—	Preço 11/09/2026 SEC 31/12/2025
RDHLRedhill Biopharma Ltd. - American Depositary Shares	NASDAQ	US$ 0,64	US$ 8,32 bi	—	-1.776,45x	176,55%	—	Preço 11/09/2026 SEC 31/12/2024
ABVXAbivax SA - American Depositary Shares	NASDAQ	US$ 105,04	US$ 8,25 bi	—	18,12x	-73,84%	—	Preço 18/09/2026 SEC 31/12/2025
PHARPharming Group N.V. - ADS, each representing 10 ordinary shares	NASDAQ	US$ 11,21	US$ 7,87 bi	2.802,50x	28,39x	0,92%	—	Preço 11/09/2026 SEC 31/12/2025
PRAXPraxis Precision Medicines, Inc. - Common Stock	NASDAQ	US$ 334,58	US$ 7,53 bi	—	8,57x	-34,54%	—	Preço 11/09/2026 SEC 31/12/2025
ALKSAlkermes plc - Ordinary Shares	NASDAQ	US$ 43,39	US$ 7,32 bi	30,34x	4,02x	13,28%	—	Preço 18/09/2026 SEC 31/12/2025
GPCRStructure Therapeutics Inc. - American Depositary Shares	NASDAQ	US$ 38,66	US$ 6,87 bi	—	4,53x	-9,31%	—	Preço 11/09/2026 SEC 31/12/2025
LEGNLegend Biotech Corporation - American Depositary Shares	NASDAQ	US$ 18,47	US$ 6,83 bi	—	6,82x	-29,62%	—	Preço 14/09/2026 SEC 31/12/2025
RYTMRhythm Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 104,71	US$ 6,80 bi	—	48,93x	-141,32%	—	Preço 11/09/2026 SEC 31/12/2025
BLTEBelite Bio, Inc - American Depositary Shares	NASDAQ	US$ 169,44	US$ 6,67 bi	—	8,65x	-10,07%	—	Preço 15/09/2026 SEC 31/12/2025
AMRXAmneal Pharmaceuticals, Inc. - Class A Common Stock	NASDAQ	US$ 18,71	US$ 6,08 bi	85,05x	-85,20x	-101,02%	—	Preço 18/09/2026 SEC 31/12/2025
KNSAKiniksa Pharmaceuticals International, plc - Class A Ordinary Shares	NASDAQ	US$ 76,27	US$ 6,02 bi	101,69x	10,61x	10,40%	—	Preço 11/09/2026 SEC 31/12/2025
TVTXTravere Therapeutics, Inc. - Common Stock	NASDAQ	US$ 66,17	US$ 5,90 bi	—	51,41x	-22,25%	—	Preço 11/09/2026 SEC 31/12/2025
PTCTPTC Therapeutics, Inc. - Common Stock	NASDAQ	US$ 66,06	US$ 5,83 bi	8,49x	-28,41x	-332,49%	—	Preço 11/09/2026 SEC 31/12/2025
LGNDLigand Pharmaceuticals Incorporated - Common Stock	NASDAQ	US$ 284,47	US$ 5,77 bi	46,41x	5,68x	12,23%	—	Preço 11/09/2026 SEC 31/12/2025
AMRNAmarin Corporation plc - American Depositary Shares	NASDAQ	US$ 13,63	US$ 5,66 bi	—	12,32x	-8,45%	—	Preço 18/09/2026 SEC 31/12/2025
LQDALiquidia Corporation - Common Stock	NASDAQ	US$ 65,15	US$ 5,61 bi	—	125,30x	-154,03%	—	Preço 14/09/2026 SEC 31/12/2025
MIRMMirum Pharmaceuticals, Inc. - common stock	NASDAQ	US$ 98,22	US$ 4,93 bi	—	15,67x	-7,42%	—	Preço 11/09/2026 SEC 31/12/2025
RADXRadiopharm Theranostics Limited - American Depositary Shares	NASDAQ	US$ 2,08	US$ 4,91 bi	—	114,46x	-89,43%	—	Preço 14/09/2026 SEC 30/06/2025
XENEXenon Pharmaceuticals Inc. - Common Shares	NASDAQ	US$ 58,65	US$ 4,65 bi	—	7,99x	-59,46%	—	Preço 11/09/2026 SEC 31/12/2025
ACADACADIA Pharmaceuticals Inc. - Common Stock	NASDAQ	US$ 27,29	US$ 4,64 bi	11,87x	3,78x	31,86%	—	Preço 18/09/2026 SEC 31/12/2025
EWTXEdgewise Therapeutics, Inc. - Common Stock	NASDAQ	US$ 44,40	US$ 4,57 bi	—	8,75x	-32,13%	—	Preço 11/09/2026 SEC 31/12/2025
ERASErasca, Inc. - Common Stock	NASDAQ	US$ 15,88	US$ 4,50 bi	—	13,85x	-38,30%	0,00%	Preço 11/09/2026 SEC 31/12/2025
INDVIndivior Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 34,49	US$ 4,41 bi	21,03x	-45,05x	-214,29%	—	Preço 11/09/2026 SEC 31/12/2025
COGTCogent Biosciences, Inc. - Common Stock	NASDAQ	US$ 32,54	US$ 4,19 bi	—	6,59x	-51,69%	—	Preço 16/09/2026 SEC 31/12/2025
DNTHDianthus Therapeutics, Inc. - Common Stock	NASDAQ	US$ 104,77	US$ 4,05 bi	—	8,20x	-32,90%	0,00%	Preço 15/09/2026 SEC 31/12/2025
TLXTelix Pharmaceuticals Limited - American Depositary Shares	NASDAQ	US$ 11,29	US$ 3,82 bi	—	9,21x	-1,72%	—	Preço 11/09/2026 SEC 31/12/2025
ABCLAbCellera Biologics Inc. - Common Shares	NASDAQ	US$ 12,63	US$ 3,77 bi	—	3,90x	-15,14%	—	Preço 18/09/2026 SEC 31/12/2025
VKTXViking Therapeutics, Inc. - Common Stock	NASDAQ	US$ 31,98	US$ 3,60 bi	—	5,64x	-56,28%	—	Preço 11/09/2026 SEC 31/12/2025
OGNOrganon & Co. Common Stock	NYSE	US$ 13,65	US$ 3,56 bi	18,95x	4,73x	24,87%	2,49%	Preço 14/09/2026 SEC 31/12/2025
IDYAIDEAYA Biosciences, Inc. - Common Stock	NASDAQ	US$ 37,59	US$ 3,33 bi	—	3,25x	-11,11%	—	Preço 11/09/2026 SEC 31/12/2025
ARQTArcutis Biotherapeutics, Inc. - Common stock	NASDAQ	US$ 25,38	US$ 3,23 bi	—	17,04x	-8,52%	—	Preço 18/09/2026 SEC 31/12/2025
PPBTPurple Biotech Ltd. - American Depositary Shares	NASDAQ	US$ 1,72	US$ 3,20 bi	63,70x	331,02x	-274,27%	—	Preço 11/09/2026 SEC 31/12/2025
ELVNEnliven Therapeutics, Inc. - Common Stock	NASDAQ	US$ 54,32	US$ 3,08 bi	—	6,70x	-22,56%	—	Preço 11/09/2026 SEC 31/12/2025
AMLXAmylyx Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 32,41	US$ 3,06 bi	—	10,04x	-47,41%	—	Preço 18/09/2026 SEC 31/12/2025
CUECue Biopharma, Inc. - Common Stock	NASDAQ	US$ 31,64	US$ 3,00 bi	—	113,40x	-100,64%	—	Preço 15/09/2026 SEC 31/12/2025
TNGXTango Therapeutics, Inc. - Common Stock	NASDAQ	US$ 23,78	US$ 2,76 bi	—	7,98x	-29,35%	—	Preço 11/09/2026 SEC 31/12/2025
NAMSNewAmsterdam Pharma Company N.V. - Ordinary Shares	NASDAQ	US$ 22,80	US$ 2,70 bi	—	3,95x	-29,82%	—	Preço 11/09/2026 SEC 31/12/2025
RCUSArcus Biosciences, Inc. Common Stock	NYSE	US$ 24,59	US$ 2,64 bi	—	4,19x	-55,94%	—	Preço 11/09/2026 SEC 31/12/2025
QUREuniQure N.V. - Ordinary Shares	NASDAQ	US$ 44,78	US$ 2,57 bi	—	12,95x	-100,04%	—	Preço 14/09/2026 SEC 31/12/2025
PHVSPharvaris N.V. - Ordinary Shares	NASDAQ	US$ 38,02	US$ 2,48 bi	—	9,14x	-64,77%	—	Preço 11/09/2026 SEC 31/12/2025
IRONDisc Medicine, Inc. - Common Stock	NASDAQ	US$ 70,06	US$ 2,47 bi	—	3,34x	-28,68%	—	Preço 11/09/2026 SEC 31/12/2025
GOSSGossamer Bio, Inc. - Common Stock	NASDAQ	US$ 10,73	US$ 2,45 bi	—	-19,97x	138,78%	—	Preço 11/09/2026 SEC 31/12/2025
HRMYHarmony Biosciences Holdings, Inc. - Common Stock	NASDAQ	US$ 41,52	US$ 2,43 bi	15,32x	2,79x	18,24%	—	Preço 11/09/2026 SEC 31/12/2025
SUPNSupernus Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 41,49	US$ 2,34 bi	—	2,21x	-3,63%	—	Preço 14/09/2026 SEC 31/12/2025
AUPHAurinia Pharmaceuticals Inc - Common Shares	NASDAQ	US$ 16,65	US$ 2,31 bi	8,04x	3,97x	49,40%	—	Preço 16/09/2026 SEC 31/12/2025
PBHPrestige Consumer Healthcare Inc. Common Stock	NYSE	US$ 46,95	US$ 2,29 bi	12,01x	1,21x	10,08%	—	Preço 11/09/2026 SEC 31/03/2026
VERAVera Therapeutics, Inc. - Class A Common Stock	NASDAQ	US$ 35,05	US$ 2,25 bi	—	3,72x	-49,56%	—	Preço 11/09/2026 SEC 31/12/2025
NRIXNurix Therapeutics, Inc. - Common stock	NASDAQ	US$ 25,90	US$ 2,24 bi	—	4,17x	-49,09%	0,00%	Preço 14/09/2026 SEC 30/11/2025
IMNMImmunome, Inc. - Common Stock	NASDAQ	US$ 24,67	US$ 2,15 bi	—	3,40x	-33,48%	—	Preço 11/09/2026 SEC 31/12/2025
MBXMBX Biosciences, Inc. - Common Stock	NASDAQ	US$ 59,02	US$ 2,15 bi	—	5,84x	-23,56%	—	Preço 11/09/2026 SEC 31/12/2025
PGENPrecigen, Inc. - Common Stock	NASDAQ	US$ 6,85	US$ 2,14 bi	—	102,53x	-1.198,61%	—	Preço 11/09/2026 SEC 31/12/2025
TRVITrevi Therapeutics, Inc. - Common Stock	NASDAQ	US$ 15,90	US$ 2,14 bi	—	11,69x	-23,33%	—	Preço 11/09/2026 SEC 31/12/2025
XTLBXTL Biopharmaceuticals Ltd. - American Depositary Shares	NASDAQ	US$ 2,43	US$ 2,14 bi	—	394,07x	-18,90%	—	Preço 14/09/2026 SEC 31/12/2024
BHCBausch Health Companies Inc. Common Stock	NYSE	US$ 5,67	US$ 2,13 bi	13,50x	5,64x	41,64%	—	Preço 15/09/2026 SEC 31/12/2025
SRPTSarepta Therapeutics, Inc. - Common Stock	NASDAQ	US$ 20,45	US$ 2,05 bi	—	1,80x	-62,55%	—	Preço 11/09/2026 SEC 31/12/2025
OCULOcular Therapeutix, Inc. - Common Stock	NASDAQ	US$ 10,83	US$ 2,03 bi	—	3,10x	-40,64%	—	Preço 14/09/2026 SEC 31/12/2025
ZYMEZymeworks Inc. - Common Stock	NASDAQ	US$ 26,24	US$ 1,98 bi	—	7,37x	-30,22%	—	Preço 11/09/2026 SEC 31/12/2025
AGIOAgios Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 33,07	US$ 1,92 bi	—	1,61x	-34,60%	—	Preço 18/09/2026 SEC 31/12/2025

Mercado internacional de ações

Ranking de Stocks

Mais populares

Todas as ações

Maiores lucros

Maiores ROEs

Maiores altas